≡

Multiplex Assay Kit for Osteoclast Associated Receptor (OSCAR) ,etc. by FLIA (Flow Luminescence Immunoassay)

PIGR3; Osteoclast Associated,Immunoglobulin-Like Receptor; Polymeric immunoglobulin receptor 3; Poly-Ig receptor 3

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Osteoclast Associated Receptor (OSCAR) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Osteoclast Associated Receptor (OSCAR) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Osteoclast Associated Receptor (OSCAR) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Osteoclast Associated Receptor (OSCAR) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-102 92
EDTA plasma(n=5) 79-93 88
heparin plasma(n=5) 81-94 86

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Osteoclast Associated Receptor (OSCAR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Osteoclast Associated Receptor (OSCAR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Osteoclast Associated Receptor (OSCAR) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 93-103% 82-103% 92-101% 94-105%
EDTA plasma(n=5) 80-102% 89-96% 81-101% 82-95%
heparin plasma(n=5) 95-103% 80-105% 78-91% 92-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:OSCAR) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Molecular and Cellular Cardiology Quantitative proteomics reveals novel functions of osteoclast-associated receptor in STAT signaling and cell adhesion in human endothelial cells PubMed: 22985931
Arthritis Research & Therapy The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints PubMed: 23146195
Inflammation Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitro article:10.1007
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES Development of a novel polysaccharide-based iron oxide nanoparticle to prevent iron accumulation-related osteoporosis by scavenging reactive oxygen … Pubmed: 33049237
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC695Hu01 Recombinant Osteoclast Associated Receptor (OSCAR) Positive Control; Immunogen; SDS-PAGE; WB.
CPC695Hu21 OVA Conjugated Osteoclast Associated Receptor (OSCAR) Immunogen; SDS-PAGE; WB.
PAC695Hu01 Polyclonal Antibody to Osteoclast Associated Receptor (OSCAR) WB; IHC; ICC; IP.
MAC695Hu22 Monoclonal Antibody to Osteoclast Associated Receptor (OSCAR) WB
SEC695Hu ELISA Kit for Osteoclast Associated Receptor (OSCAR) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC695Hu Multiplex Assay Kit for Osteoclast Associated Receptor (OSCAR) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.